Use of Hormone Replacement in Females with Endocrine Disorders
- PMID: 28376481
- DOI: 10.1159/000457125
Use of Hormone Replacement in Females with Endocrine Disorders
Abstract
Hormone replacement therapy (HRT) is necessary in adolescents with primary ovarian insufficiency (POI) in order to avoid estrogen deficiency. The goal of this minirewiew is to present the different types of estrogens (17β-estradiol, estradiol valerate, ethinyl estradiol, and combined equine estrogens) as well as the different types of progestins available. In order to choose among the different types of HRTs, the features of each regimen are being discussed as well as their risks and their respective benefits. The differences between oral combined contraceptive pills and a dissociated regimen containing estrogen and progestins are emphasized. The different effects of HRTs, mainly on feminization, growth spurt, bone mass as well as cardiovascular risk, and the follow-up of these young patients are presented. HRT in adolescents and young adults with estrogen deficiency is necessary and should be continued until the age of natural menopause. Studies have so far essentially included children or adolescents with Turner syndrome. Therefore, studies on HRT including patients with POI and a normal karyotype are necessary.
Keywords: Contraceptive pill; Estrogen; Premature ovarian insufficiency; Progestin.
© 2017 S. Karger AG, Basel.
Similar articles
-
Quantification of the adverse effect of ethinylestradiol containing oral contraceptive pills when used in conjunction with growth hormone replacement in routine practice.Clin Endocrinol (Oxf). 2012 May;76(5):729-33. doi: 10.1111/j.1365-2265.2011.04277.x. Clin Endocrinol (Oxf). 2012. PMID: 22098528
-
The adverse effects of hormonal therapy.Cardiol Clin. 1986 Feb;4(1):145-52. Cardiol Clin. 1986. PMID: 3518931 Review.
-
Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.Expert Rev Clin Pharmacol. 2017 Oct;10(10):1129-1144. doi: 10.1080/17512433.2017.1356718. Epub 2017 Aug 7. Expert Rev Clin Pharmacol. 2017. PMID: 28712325 Review.
-
Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.Acta Endocrinol (Copenh). 1991;125 Suppl 1:13-26. Acta Endocrinol (Copenh). 1991. PMID: 1801500 Review.
-
The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S9-13. doi: 10.1016/j.ajog.2011.06.057. Am J Obstet Gynecol. 2011. PMID: 21961825 Review.
Cited by
-
Estradiol treatment increases M2-like visceral adipose tissue macrophages in obese ovariectomized mice regardless of its anorectic action.Anim Cells Syst (Seoul). 2022 Sep 29;26(5):243-253. doi: 10.1080/19768354.2022.2128871. eCollection 2022. Anim Cells Syst (Seoul). 2022. PMID: 36275444 Free PMC article.
-
Combined Intranasal Insulin/Saxagliptin/Metformin Therapies Ameliorate the Effect of Combined Oral Contraceptive- (COC-) Induced Metabolic Syndrome (MetS) with a Major Target on Glucose Metabolism in Adult Female Wistar Rats.Int J Reprod Med. 2021 Dec 13;2021:9693171. doi: 10.1155/2021/9693171. eCollection 2021. Int J Reprod Med. 2021. PMID: 34938803 Free PMC article.
-
Human Ovarian Follicles Xenografted in Immunoisolating Capsules Survive Long Term Implantation in Mice.Front Endocrinol (Lausanne). 2022 Jun 3;13:886678. doi: 10.3389/fendo.2022.886678. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35721740 Free PMC article.
-
Effect of Donor Age on Endocrine Function of and Immune Response to Ovarian Grafts.Int J Mol Sci. 2024 Mar 19;25(6):3431. doi: 10.3390/ijms25063431. Int J Mol Sci. 2024. PMID: 38542404 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical